Scientometric Analysis of Global Scientific Publications on COVID-19 and Diabetes with an Emphasis on Middle Eastern Countries.

IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM

International Journal of Endocrinology and Metabolism Pub Date : 2022-08-15 eCollection Date: 2022-07-01 DOI:10.5812/ijem-120812

Rasha Atlasi, Ozra Tabatabaei-Malazy, Fatemeh Bandarian, Nafiseh Rezaei, Pouria Khashayar, Bagher Larijani

{"title":"Scientometric Analysis of Global Scientific Publications on COVID-19 and Diabetes with an Emphasis on Middle Eastern Countries.","authors":"Rasha Atlasi, Ozra Tabatabaei-Malazy, Fatemeh Bandarian, Nafiseh Rezaei, Pouria Khashayar, Bagher Larijani","doi":"10.5812/ijem-120812","DOIUrl":null,"url":null,"abstract":"Background: Due to the worldwide spread of COVID-19, various countries have designed scientific studies on different aspects of the disease. Patients with diabetes mellitus (DM) have been proven to be at higher risk of COVID-19-related complications, hospitalization, and death.Objectives: The aim was to conduct a scientometric analysis of scholarly outputs on diabetes and COVID-19.Methods: Web of Science was searched for scientific publications on diabetes and COVID-19 by Middle Eastern researchers until September 14, 2021. Collected data were analyzed for document type, subject area, countries, top journals, citation number, and authors' collaboration network using VOS viewer 1.6.15 and bibliometrix R-package 4.1.1.Results: Overall, the characteristics of 603 documents on DM and COVID-19 were analyzed. The top three productive countries in the field were Iran, Turkey, and Saudi Arabia. The top affiliation was from Iran; \"Tehran University of Medical Sciences\" (n = 168), followed by \"Shahid Beheshti University of Medical Sciences\" (n = 82). The total citation number was 3704 times. The highest cited paper (348) was a systematic review from Iran, published in arch Acad Emerg Med. The top source was \"Diabetes & Metabolic Syndrome: Clinical Research & Reviews,\" with 26 documents.Conclusions: The current study provides an overview of the quantity and quality of published scholarly documents on the intersection of DM and COVID-19 in the region. Our findings help scientists find the existing gaps, manage the research budgets, identify active authors and scientific institutes to collaborate with, and use their experience to produce new knowledge in the future.","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 3","pages":"e120812"},"PeriodicalIF":2.1000,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/5a/ijem-20-3-120812.PMC9661537.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology and Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5812/ijem-120812","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 1

Abstract

Background: Due to the worldwide spread of COVID-19, various countries have designed scientific studies on different aspects of the disease. Patients with diabetes mellitus (DM) have been proven to be at higher risk of COVID-19-related complications, hospitalization, and death.

Objectives: The aim was to conduct a scientometric analysis of scholarly outputs on diabetes and COVID-19.

Methods: Web of Science was searched for scientific publications on diabetes and COVID-19 by Middle Eastern researchers until September 14, 2021. Collected data were analyzed for document type, subject area, countries, top journals, citation number, and authors' collaboration network using VOS viewer 1.6.15 and bibliometrix R-package 4.1.1.

Results: Overall, the characteristics of 603 documents on DM and COVID-19 were analyzed. The top three productive countries in the field were Iran, Turkey, and Saudi Arabia. The top affiliation was from Iran; "Tehran University of Medical Sciences" (n = 168), followed by "Shahid Beheshti University of Medical Sciences" (n = 82). The total citation number was 3704 times. The highest cited paper (348) was a systematic review from Iran, published in arch Acad Emerg Med. The top source was "Diabetes & Metabolic Syndrome: Clinical Research & Reviews," with 26 documents.

Conclusions: The current study provides an overview of the quantity and quality of published scholarly documents on the intersection of DM and COVID-19 in the region. Our findings help scientists find the existing gaps, manage the research budgets, identify active authors and scientific institutes to collaborate with, and use their experience to produce new knowledge in the future.

Abstract Image

查看原文本刊更多论文

关于COVID-19和糖尿病的全球科学出版物的科学计量分析，重点是中东国家。

背景:由于COVID-19在全球范围内的传播，各国都对该疾病的不同方面进行了科学研究。事实证明，糖尿病患者出现covid -19相关并发症、住院和死亡的风险更高。目的:对糖尿病和COVID-19的学术成果进行科学计量分析。方法:在Web of Science检索中东研究人员关于糖尿病和COVID-19的科学出版物，截止到2021年9月14日。使用VOS viewer 1.6.15和bibliometrix R-package 4.1.1对收集到的数据进行文献类型、学科领域、国家、顶级期刊、被引次数和作者协作网络等分析。结果:共分析603份DM和COVID-19相关文献的特点。该领域产量最高的三个国家是伊朗、土耳其和沙特阿拉伯。排名靠前的是伊朗;"德黑兰医科大学"(168名)，其次是"Shahid Beheshti医科大学"(82名)。总被引次数3704次。引用率最高的论文(348)是一篇来自伊朗的系统综述，发表在《arch Acad emerging Med》上。排名第一的是《糖尿病与代谢综合征:临床研究与评论》，共有26篇论文。结论:本研究概述了该地区关于糖尿病与COVID-19交叉的已发表学术文献的数量和质量。我们的发现帮助科学家发现现有的差距、管理研究预算、确定活跃的作者和可以合作的科研机构，并利用他们的经验在未来产生新的知识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Endocrinology and Metabolism ENDOCRINOLOGY & METABOLISM-

CiteScore

3.10

自引率

4.80%

发文量

期刊介绍： The aim of the International Journal of Endocrinology and Metabolism (IJEM) is to increase knowledge, stimulate research in the field of endocrinology, and promote better management of patients with endocrinological disorders. To achieve this goal, the journal publishes original research papers on human, animal and cell culture studies relevant to endocrinology.